Clinical trial
A Clinical Evaluation of the RheOx Bronchial Rheoplasty System for the Treatment of the Symptoms of Chronic Bronchitis in Chinese Adult Patients With COPD
NCT05641207 is registered in ClinicalTrials.gov with Energenx Medical LTD. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Evaluation of the RheOx Bronchial Rheoplasty System for the Treatment of the Symptoms of Chronic Bronchitis in Chinese Adult Patients With COPD
- Lead sponsor
- Energenx Medical LTD.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 18, 2023
- Completion date
- June 30, 2026
- Enrollment
- 40 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
chronic bronchitis, chronic obstructive pulmonary disease